Martin Engelstadter

Title: Martin Engelstadter: Innovator in Gene Transfer Technology

Introduction

Martin Engelstadter is a notable inventor based in Roedermark, Germany. He has made significant contributions to the field of gene transfer technology, particularly through his innovative work on retroviral vectors. His expertise and inventions have the potential to impact various applications in medicine and biotechnology.

Latest Patents

Engelstadter holds a patent for "Cell-specific retroviral vectors with antibody domains and method for the production thereof for selective gene transfer." This invention focuses on the development of cell-specific retroviral vectors that incorporate antibody recognition domains (scFv). These vectors are designed for the targeted transduction of specific mammalian cell types, enhancing the precision of gene transfer processes. The patent also covers methods for producing these vectors and their application in gene transfers into selected cells.

Career Highlights

Throughout his career, Martin Engelstadter has been associated with Bundesrepublik Deutschland, where he has contributed to advancements in gene therapy and biotechnology. His work has been instrumental in developing technologies that facilitate targeted gene delivery, which is crucial for therapeutic applications.

Collaborations

Engelstadter has collaborated with Klaus Cichutek, a fellow expert in the field. Their partnership has likely fostered innovative approaches to gene transfer technologies, although specific details of their collaborations are not provided.

Conclusion

Martin Engelstadter's contributions to the field of gene transfer technology through his patented innovations highlight his role as a key inventor in this area. His work continues to pave the way for advancements in targeted gene therapy and biotechnology.